DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San ...
The Trump Administration reversed course on plans to terminate the lease of a major Food and Drug Administration quality lab ...
Chemicals such as titanium dioxide and potassium bromate, whose safety has been debated, are allowed in foods in the United ...
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.
and Mesa, Ariz. related to concerns about manufacturing processes and quality management systems. The FDA cited issues with DexCom's response to prior inspection findings, known as Form 483 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results